Rechercher dans la communauté
Affichage des résultats pour les étiquettes 'revenues'.
3 résultats trouvés
-
New York City fears return to 1970s Tue Jan 27, 2009 By Joan Gralla http://www.reuters.com/article/newsO...50Q6IH20090127
-
Liberals refuse to confirm report Ontario to run near $1-billion deficit Wed, 2008-10-22 13:04. By: THE CANADIAN PRESS TORONTO - The Ontario government refused to confirm Wednesday in advance of handing down its fall economic update that the province will run a deficit of almost $1 billion this year because of the world financial crisis. For the past two weeks, Premier Dalton McGuinty has signalled he is prepared to run a deficit because of declining government revenues. In the legislature, Opposition Leader Bob Runciman wanted to know how Ontario went from a balanced budget four weeks ago to what he said was an expected deficit of $1 billion. "Less than a month ago, (Finance Minister Dwight Duncan) said the budget would be balanced, even with a downturn in the U.S. economy," Runciman said. "Premier, how is it that just four short weeks ago the budget was balanced, but today there's going to be a deficit of almost $1 billion?" McGuinty told the house he didn't know where Runciman was getting his numbers. People would have to wait until the finance minister delivers the fall economic update later Wednesday to see what red ink exists, McGuinty said. "We're in a pretty good position now to withstand these powerful winds that are blowing out there," he said. But, McGuinty added, the government also has to find a way to "make advances on the poverty front, to act in a way that is fiscally responsible, to protect health care and to protect education." On Monday, McGuinty said he told Duncan not to run a deficit unless not doing so would mean cutting back on public services. He also vowed that Ontario would not close hospitals or cancel infrastructure programs after more than 200,000 people lost their jobs. On Tuesday, he warned schools, cities and hospitals that funding projections would have to be scaled back during challenging times that may last as long as two years. Government officials will say only that Duncan's statement will outline which new government programs will have to be delayed because of falling revenues. Anti-poverty activists are worried that will mean the government will fail to keep its promise to help the poorest of the poor improve their living standards. -
Draxis to create up to 100 jobs after chosen by J&J for contract manufacturing
un sujet a posté mtlurb dans L'actualité
Draxis to create up to 100 jobs after chosen by J&J for contract manufacturing 6 days ago MONTREAL (CP) — Pharma company Draxis Health Inc. (TSX:DAX) is building a new Montreal plant and hiring up to 100 people after the company's contract manufacturing division expanded its existing relationship with Johnson & Johnson, one of the world's biggest consumer products companies. The contract expansion will lead to between 80 to 100 new positions at Draxis Pharma operations in the Montreal area and require the building of a new secondary plant, in addition to the current Draxis manufacturing plant in suburban Kirkland, the company said Wednesday. On the Toronto Stock Exchange, Draxis stock jumped 34 cents to trade at $5.39, a gain of 6.7 per cent as investors reacted positively to the news. Draxis said the new deal with Johnson & Johnson Consumer Companies Inc. could mean another US$120 million in revenues over five years to the Canadian company. In addition, the transfer of equipment and production technologies, now in progress, is expected to generate additional revenues this year and next of between US$6 million and US$8 million. The supply deal, which runs to the end of 2013 and can be extended, involves the manufacturing of non-sterile specialty semi-solid products currently sold in the United States. Commercial production is expected to begin in 2009. "The signing of this contract is a reflection of the solid business model at Draxis," said Martin Barkin, president and CEO of the Toronto-area company. "We are honoured to have been selected from more than 80 international contract manufacturers under a rigorous and comprehensive global selection process conducted over an extended multi-year period. "This contract includes prescription and non-prescription products and will significantly improve capacity utilization in the semi-solids section of our non-sterile operations." As a result of the manufacturing deal, Draxis plans to build a new secondary plant to handle labeling, product assembly for different markets, cartoning and shipping. The new operation is slated to open next summer and will complement the company's production plant in Kirkland, in west-end Montreal. The jobs expansion is good news for the local Montreal economy, which has also seen other drug developers expand operations in recent months. In June, global drug giant GlaxoSmithKline (NYSE:GSK) announced it has spent $50 million to upgrade its laboratory north of Montreal into the North American research and administrative headquarters for its vaccine division. GlaxoSmithKline, based in Britain, is a world leader in the vaccine business. The company has 3,300 employees in Canada, including 1,400 in Quebec. Draxis, based in Mississauga, Ont. makes sterile products such as injectable liquids, ointments and creams, non-sterile products as well as radiopharmaceuticals for diagnostic imaging and treatment. The company employs about 500 people at its Montreal plant. Last year, Draxis generated a profit of US$11.5 million on revenues of just under US$90 million.
